PTCB MTM EXAM PREPARATION
QUESTIONS AND ANSWERS WITH
VERIFIED SOLUTIONS (GRADED A+)
1. What are pharmaceutical equivalents?
Answer: Pharmaceutical equivalents contain the same active ingredients,
dosage form, and route of administration. They are identical in strength or
concentration.
2. What are pharmaceutical alternatives?
Answer: Pharmaceutical alternatives are drugs with different salts, esters, or
complexes. They may also have different dosage forms or strengths, like
tablets versus capsules. Data is often unavailable for FDA determination of
tablet to capsule equivalence.
3. What does bioavailability refer to?
Answer: Bioavailability is the rate and extent to which an active ingredient
is absorbed and becomes available at the drug's site of action.
4. What is bioequivalence?
Answer: Bioequivalence is when the rate and extent of absorption of a
generic drug are not significantly different from the brand name drug, under
similar conditions. The drug’s effectiveness remains the same during chronic
use, even if the absorption rate differs slightly.
5. What are biosimilars?
Answer: Biosimilars are biologic products derived from a different cell line,
highly similar to the FDA-approved reference product. They have no
clinically meaningful differences in safety, purity, or potency.
QUESTIONS AND ANSWERS WITH
VERIFIED SOLUTIONS (GRADED A+)
1. What are pharmaceutical equivalents?
Answer: Pharmaceutical equivalents contain the same active ingredients,
dosage form, and route of administration. They are identical in strength or
concentration.
2. What are pharmaceutical alternatives?
Answer: Pharmaceutical alternatives are drugs with different salts, esters, or
complexes. They may also have different dosage forms or strengths, like
tablets versus capsules. Data is often unavailable for FDA determination of
tablet to capsule equivalence.
3. What does bioavailability refer to?
Answer: Bioavailability is the rate and extent to which an active ingredient
is absorbed and becomes available at the drug's site of action.
4. What is bioequivalence?
Answer: Bioequivalence is when the rate and extent of absorption of a
generic drug are not significantly different from the brand name drug, under
similar conditions. The drug’s effectiveness remains the same during chronic
use, even if the absorption rate differs slightly.
5. What are biosimilars?
Answer: Biosimilars are biologic products derived from a different cell line,
highly similar to the FDA-approved reference product. They have no
clinically meaningful differences in safety, purity, or potency.
